Gilead To Present At Three Upcoming Investor Conferences In September

- Citi’s 11^th Annual Biotech Conference -

- 2016 Wells Fargo Healthcare Conference -

- Morgan Stanley Global Healthcare Conference -

- Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts from three upcoming investor conferences: Citi’s 11^th Annual Biotech Conference, the 2016 Wells Fargo Healthcare Conference and the Morgan Stanley Global Healthcare Conference.

Kevin Young CBE, Gilead’s Chief Operating Officer and Norbert W. Bischofberger, PhD, Gilead’s Executive Vice President, R&D and Chief Scientific Officer, will participate in fireside chats at Citi’s 11^th Annual Biotech Conference on Wednesday, September 7 at 11:00 a.m. Eastern Time (ET) and the 2016 Wells Fargo Healthcare Conference on Thursday, September 8 at 9:55 a.m. ET, both taking place in Boston.

John F. Milligan, PhD, Gilead’s President and Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12 at 9:20 a.m. ET in New York.

The audio portion of the fireside chats will be accessible live through the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.